Certified by Founder
Lodge
Ancilia Biosciences
start up
United States
- New York, New York
- 29/08/2024
- Unknown
- $4,200,000
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
- Industry Biotechnology
- Website https://www.anciliabio.com/
- LinkedIn https://www.linkedin.com/company/ancilia/
Simple AI | $14,000,000 | (Feb 12, 2026)
Hubbl Technologies | $6,000,000 | (Feb 12, 2026)
Trener Robotics (formerly T-ROBOTICS) | $32,000,000 | (Feb 12, 2026)
Complyance | $20,000,000 | (Feb 12, 2026)
Brandlight | $30,000,000 | (Feb 12, 2026)
Tenna Systems | $13,500,000 | (Feb 12, 2026)
GitGuardian | $50,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)
Birch Hill Holdings | $2,500,000 | (Feb 12, 2026)
Smart Bricks | $5,000,000 | (Feb 12, 2026)
Scala | $8,500,000 | (Feb 12, 2026)
Loyal | $100,000,000 | (Feb 12, 2026)